BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9088587)

  • 1. Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.
    Spina E; Avenoso A; Campo GM; Scordo MG; Caputi AP; Perucca E
    Br J Clin Pharmacol; 1997 Mar; 43(3):315-8. PubMed ID: 9088587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Perucca E; Caputi AP
    Ther Drug Monit; 1993 Jun; 15(3):243-6. PubMed ID: 8333005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.
    Bergstrom RF; Peyton AL; Lemberger L
    Clin Pharmacol Ther; 1992 Mar; 51(3):239-48. PubMed ID: 1544284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of sertraline on the pharmacokinetics of desipramine and imipramine.
    Kurtz DL; Bergstrom RF; Goldberg MJ; Cerimele BJ
    Clin Pharmacol Ther; 1997 Aug; 62(2):145-56. PubMed ID: 9284850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies.
    Venkatakrishnan K; Schmider J; Harmatz JS; Ehrenberg BL; von Moltke LL; Graf JA; Mertzanis P; Corbett KE; Rodriguez MC; Shader RI; Greenblatt DJ
    J Clin Pharmacol; 2001 Oct; 41(10):1043-54. PubMed ID: 11583471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin.
    Böttiger Y; Tybring G; Götharson E; Bertilsson L
    Clin Pharmacol Ther; 1997 Oct; 62(4):384-91. PubMed ID: 9357389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of troleandomycin on the pharmacokinetics of imipramine in Chinese: the role of CYP3A.
    Wang JS; Wang W; Xie HG; Huang SL; Zhou HH
    Br J Clin Pharmacol; 1997 Aug; 44(2):195-8. PubMed ID: 9278210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4.
    Madsen H; Rasmussen BB; Brøsen K
    Clin Pharmacol Ther; 1997 Mar; 61(3):319-24. PubMed ID: 9084457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity.
    Brynne N; Forslund C; Hallén B; Gustafsson LL; Bertilsson L
    Br J Clin Pharmacol; 1999 Oct; 48(4):564-72. PubMed ID: 10583027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
    Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1989; 37(2):155-60. PubMed ID: 2792169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipramine metabolism in relation to the sparteine and mephenytoin oxidation polymorphisms--a population study.
    Madsen H; Nielsen KK; Brøsen K
    Br J Clin Pharmacol; 1995 Apr; 39(4):433-9. PubMed ID: 7640151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenobarbital induces the 2-hydroxylation of desipramine.
    Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
    Ther Drug Monit; 1996 Feb; 18(1):60-4. PubMed ID: 8848823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of venlafaxine on imipramine metabolism.
    Albers LJ; Reist C; Vu RL; Fujimoto K; Ozdemir V; Helmeste D; Poland R; Tang SW
    Psychiatry Res; 2000 Nov; 96(3):235-43. PubMed ID: 11084219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of In Vitro Data and Physiologically-Based Pharmacokinetic Modeling to Predict Drug Metabolite Exposure: Desipramine Exposure in Cytochrome P4502D6 Extensive and Poor Metabolizers Following Administration of Imipramine.
    Nguyen HQ; Callegari E; Obach RS
    Drug Metab Dispos; 2016 Oct; 44(10):1569-78. PubMed ID: 27440861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation.
    Chiba K; Saitoh A; Koyama E; Tani M; Hayashi M; Ishizaki T
    Br J Clin Pharmacol; 1994 Mar; 37(3):237-42. PubMed ID: 8198931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole.
    Harris RZ; Salfi M; Sullivan JT; Padhi D
    Clin Pharmacokinet; 2007; 46(6):495-501. PubMed ID: 17518508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of imipramine N-demethylation by fluvoxamine in Chinese young men.
    Xu ZH; Huang SL; Zhou HH
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):399-402. PubMed ID: 9863158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative bioavailability of imipramine (Tofranil) coated tablets in healthy volunteers.
    Ullmann U; Lehnfeld R; Bliesath H; Birkel M; Gebbing H; Gräve M; Wolf H
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):271-6. PubMed ID: 11430636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin.
    Kerbusch T; Jansen RL; Mathôt RA; Huitema AD; Jansen M; van Rijswijk RE; Beijnen JH
    Clin Pharmacol Ther; 2001 Aug; 70(2):132-41. PubMed ID: 11503007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of partially purified P450 2D18 and characterization of activity toward the tricyclic antidepressants imipramine and desipramine.
    Thompson CM; Kawashima H; Strobel HW
    Arch Biochem Biophys; 1998 Nov; 359(1):115-21. PubMed ID: 9799568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.